spiromustine has been researched along with Benign Neoplasms, Brain in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjerkvig, R; Deen, DF; Hoshino, T; Sano, Y | 1 |
Bartle, PM; Deen, DF; Hoshino, T; Nomura, K; Williams, ME | 1 |
Bartle, PM; Deen, DF; Williams, ME | 1 |
DeVroom, HL; Resio, MJ | 1 |
Levin, V; Prados, M; Rodriguez, L; Seager, M; Silver, P | 1 |
Kobayashi, T | 1 |
Da Silva, VF; Feeley, M; Goyal, R; Raaphorst, GP | 1 |
Deen, DF; Jostes, RF; Williams, ME | 1 |
8 other study(ies) available for spiromustine and Benign Neoplasms, Brain
Article | Year |
---|---|
The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustard.
Topics: Animals; Brain Neoplasms; Cell Count; Cell Cycle; Cell Line; Cell Survival; Cells, Cultured; Centrifugation; DNA; Flow Cytometry; Hydantoins; Nitrogen Mustard Compounds; Rats; Time Factors; Tumor Stem Cell Assay | 1983 |
Response of 9L tumor cells in vitro to spirohydantoin mustard.
Topics: Animals; Brain Neoplasms; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hydantoins; Neoplasms, Experimental; Nitrogen Mustard Compounds; Radiation-Sensitizing Agents; Rats; Time Factors | 1979 |
Response of cultured 9L cells to spirohydantoin mustard and X-rays.
Topics: Animals; Brain Neoplasms; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Hydantoins; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats; Time Factors | 1979 |
Spiromustine and intracarotid artery cisplatin in the treatment of glioblastoma multiforme.
Topics: Brain Neoplasms; Carotid Arteries; Cisplatin; Combined Modality Therapy; Drug Evaluation; Glioblastoma; Humans; Hydantoins; Infusions, Intra-Arterial; National Institutes of Health (U.S.); Nitrogen Mustard Compounds; Oncology Nursing; United States | 1986 |
Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.
Topics: Adult; Brain Neoplasms; Diagnosis-Related Groups; Drug Evaluation; Female; Glioma; Humans; Hydantoins; Male; Middle Aged; Nitrogen Mustard Compounds; Physostigmine | 1987 |
[New developments in chemotherapy for experimental brain metastasis].
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Daunorubicin; Doxorubicin; Floxuridine; Hydantoins; Leukemia, Myeloid; Liver Neoplasms, Experimental; Lomustine; Meningeal Neoplasms; Methotrexate; Neoplasm Transplantation; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Procarbazine; Rats | 1985 |
Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Cyclohexenes; Glioma; Hot Temperature; Humans; Hydantoins; In Vitro Techniques; Nitrogen Mustard Compounds | 1987 |
The effect of treatment with single and split doses of spirohydantoin mustard on the growth delay of 9L rat brain tumor multicellular spheroids.
Topics: Animals; Brain Neoplasms; Cell Survival; Cells, Cultured; Hydantoins; Nitrogen Mustard Compounds; Rats; Time Factors | 1985 |